[1]石红梅.人参归脾丸对缺铁性贫血患者HB、RBC、HCT的影响[J].西部中医药,2013,26(03):80-81.
 SHI Hongmei.Effect of RenShen GuiPiW an on HGB, RBC and HCT of Patients with Iron-deficiency Anemia[J].Western Journal of Traditional Chinese Medicine,2013,26(03):80-81.
点击复制

人参归脾丸对缺铁性贫血患者HB、RBC、HCT的影响
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年03期
页码:
80-81
栏目:
报道·临证经验
出版日期:
2013-03-15

文章信息/Info

Title:
Effect of RenShen GuiPiW an on HGB, RBC and HCT of Patients with Iron-deficiency Anemia
文章编号:
1004-6852(2013)03-0080-02
作者:
石红梅
陇西县第一人民医院检验科,甘肃 陇西 748100
Author(s):
SHI Hongmei
Clinical Laboratory of Longxi County the First People's Hospital, Longxi 748100, China
关键词:
贫血缺铁性血红蛋白红细胞血细胞比容人参归脾丸
Keywords:
anemia iron-deficiency hemoglobin (HB) red blood cell (RBC) hematocrit (HCT)RenShen GuiPiWan
分类号:
R556.3
文献标志码:
B
摘要:
目的:观察人参归脾丸对缺铁性贫血(IDA)患者血红蛋白(HB)、红细胞(RBC)、血细胞比容(HCT)的影响。方法:将 80 例 IDA 患者随机分为观察组和对照组各 40 例。2 组均服用琥珀酸亚铁片,0.1 g/ 次,3 次 /d,同时每次给予等量维生素 C 同服以利吸收;观察组同时给予人参归脾丸,9 g/ 次,3 次 /d。2 组均以治疗 1 个月为 1 个疗程,治疗 1 个疗程后评价疗效。结果:治愈率观察组为 80.00%,对照组为 50.00%,2 组相比差异显著(P<0.05)。总有效率观察组为 95.00%,对照组为 75.00%,2 组相比差异显著(P<0.05)。HB、RBC、HCT治疗后 2 组均明显增高 (P<0.05),治疗后组间比较差异显著(P<0.05)。结论:人参归脾丸可改善 IDA 患者HB、RBC、HCT 指标。
Abstract:
Objective: To verify the effects of RenShen GuiPiWan on hemoglobin (HB), red blood cell (RBC) and hematocrit (HCT) of patients suffering from iron-deficiency anemia. Method: Eighty patients were randomly separated into the observation group and the control group. Both groups took ferrous succinate tablets,0.1 g once, three times each day, and the same amounts of vitamin C to promote absorption; the observation group received RenShen GuiPiWan, 9 g once, three times each day. One course of treatment was one month, clinical effects were observed after treating for one course of treatment. Result: Cure rate of the observation group was 80.00%, higher than 50.00% of the control group with significant difference (P< 0.05). Total effective rates of the observation group and the control group were 95.00% and 75.00%, comparison between both groups demonstrated significant difference (P< 0.05). HB, RBC and HCT were improved of both groups after treating (P < 0.05),comparison between both groups showed significant difference (P< 0.05). Conclusion: RenShen GuiPiWan could improve the indexes including HB, RBC and HCT.

参考文献/References:

[1] 李迎春,王彪.缺铁性贫血的诊断和鉴别诊断[J].中国实用乡村医生杂志,2008,15(6):7-8. [2] 许文荣,王建中.临床血液学和血液学检验[M].4 版.北京:人民卫生出版社,2007:7. [3] 张文龙,王曼萍,张骥,等.慢性病贫血的铁代谢研究[J].临床血液学杂志,2008,21(6):588-589. [4] 魏小平,马泽荣,郑贵星,等.骨髓铁与常用血清铁指标的相关性研究[J].国际检验医学杂志,2011,32(14):1546-1547. [5] 秦春优.中西医结合治疗小儿缺铁性贫血77例观察[J].甘肃中医,2007,20(1):29-30. [6] 张会云,田利军,高茉丽,等.中医治未病理论在小儿营养性缺铁性贫血预防中的应用[J].河北中医,2011,33(7):1016-1017.

相似文献/References:

[1]黄邦荣,张东鹏△.裴正学教授治疗再生障碍性贫血的经验[J].西部中医药,2013,26(07):37.
 HUANG Bangrong,ZHANG Dongpeng.Professor PEI Zhengxue′s Experience of Treating Aplastic Anemia[J].Western Journal of Traditional Chinese Medicine,2013,26(03):37.
[2]夏小军,段赟.中医药治疗自身免疫性溶血性贫血的思路与方法[J].西部中医药,2016,29(02):41.
 XIA Xiaojun,DUAN Yun.Thinking and Methods of TCM in the Treatment for Autoimmune Hemolytic Anemia[J].Western Journal of Traditional Chinese Medicine,2016,29(03):41.

备注/Memo

备注/Memo:
收稿日期:2012-10-18 作者简介:石红梅(1970—),女,主管检验师。研究方向:临床基础检验。
更新日期/Last Update: 2013-03-15